FSD Pharma Inc.

HUGE · NASDAQ
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Assets
Cash & Equivalents$3,307$1,330$2,743$3,634
Short-Term Investments$22$759$752$744
Receivables$6,563$6,821$7,379$4,520
Inventory$0$0$0$347
Other Curr. Assets$0$0$0$0
Total Curr. Assets$10,022$9,191$11,029$9,246
Property Plant & Equip (Net)$73$105$120$136
Goodwill$0$0$0$0
Intangibles$5,146$5,251$5,356$5,462
Long-Term Investments$6$6$909$109
Tax Assets$0$0-$5,356$3,996
Other NC Assets$0$0$5,328-$8
Total NC Assets$5,225$6,247$6,357$9,695
Other Assets$0$0$0$0
Total Assets$15,247$15,423$17,385$18,942
Liabilities
Payables$3,603$2,625$3,241$2,665
Short-Term Debt$616$600$301$301
Tax Payable$0$0$0$0
Deferred Revenue$0$0-$3,241$1,037
Other Curr. Liab.$0$43$8$130
Total Curr. Liab.$5,045$3,920$4,542$4,195
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$10$24$39$62
Total Liabilities$5,045$3,924$4,542$4,195
Equity
Pref Stock$0$0$0$0
Common Stock$140,706$138,507$137,778$137,758
Retained Earnings-$162,923-$159,812-$157,908-$156,505
AOCI$83$185$417$702
Other Equity$2,437$2,435$2,656$2,681
Total Equity$10,958$12,030$13,169$14,836
Supplemental Information
Minority Interest-$756-$516-$326-$90
Total Liab. & Tot. Equity$15,247$15,439$17,385$18,942
Net Debt-$2,691-$730-$2,442-$3,333